International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2021 - Volume 25, Number 5
View All Articles in Issue

Page(s): 415

Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr, PhD, RPh, dapsone, sulphone antibiotic, formulation, oral suspension, leprosy, pneumocystis pneumonia, malaria, dermatitis herpetiformis, dermatoses, acne, toxoplasmosis, actinomycetoma

Related Categories: DERMATOLOGY, FORMULATIONS, INFECTIOUS DISEASE

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 415
Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2017 Pg. 491
Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 47
Dapsone 2-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2006 Pg. 300
Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 44
Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 416
Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 505
Dapsone 2 mg/mL in Ora-Sweet and Ora-Plus Allen Loyd V Jr	Jan/Feb 2023 Pg. 52
Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension Allen Loyd V Jr	May/Jun 2018 Pg. 235
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Hydroxychloroquine Sulfate 25 mg/mL in Oral Mix or Oral Mix SF Allen Loyd V Jr	Nov/Dec 2017 Pg. 494
Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets Kaila Nitin, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D	May/Jun 2003 Pg. 233-239
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Naproxen 25 mg/mL in Oral Mix or Oral Mix SF Allen Loyd V Jr	Jan/Feb 2018 Pg. 54
Hydrocortisone 2-mg/mL in Oral Mix Suspension Allen Loyd V Jr	Jul/Aug 2021 Pg. 325
Stability of Allopurinol in Extemporaneously Compounded Oral Suspensions with Oral Mix and Oral Mix SF Friciu Mihaela, Cull Erica, Leclair Grégoire	Sep/Oct 2024 Pg. 408-412
Temozolomide 10 mg/mL in Oral Mix SF Suspension Allen Loyd V Jr	May/Jun 2021 Pg. 235
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Prednisone 5 mg/mL ir Oral Mix Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 497
Stability of Prednisone in Oral Mix Suspending Vehicle Friciu Mihaela, Plourde Kevin, Leclair Grégoire, Danapoulos Panagiota, Savji Taslim	Jul/Aug 2015 Pg. 337-339
Return to Top